Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease

Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease

Release Date: August, 2023|Copyright: © 2023 |Pages: 447
DOI: 10.4018/978-1-6684-5156-4
ISBN13: 9781668451564|ISBN10: 1668451565|EISBN13: 9781668451571
Hardcover:
Forthcoming
$325.00
TOTAL SAVINGS: $325.00
Benefits
  • Printed-On-Demand (POD)
  • Usually ships one day from order
Hardcover:
Forthcoming
$325.00
TOTAL SAVINGS: $325.00
Benefits
  • Printed-On-Demand (POD)
  • Usually ships one day from order
E-Book:
Available
$325.00
TOTAL SAVINGS: $325.00
Benefits
  • Multi-user license (no added fee)
  • Immediate access after purchase
  • No DRM
  • PDF download
E-Book:
Available
$325.00
TOTAL SAVINGS: $325.00
Benefits
  • Immediate access after purchase
  • No DRM
  • PDF download
  • Receive a 10% Discount on eBooks
Hardcover +
E-Book:
Forthcoming
$390.00
TOTAL SAVINGS: $390.00
Benefits
  • Printed-On-Demand (POD)
  • Usually ships one day from order
  • Multi-user license (no added fee)
  • Immediate access after purchase
  • No DRM
  • PDF download
Hardcover +
E-Book:
Forthcoming
$390.00
TOTAL SAVINGS: $390.00
Benefits
  • Printed-On-Demand (POD)
  • Usually ships one day from order
  • Immediate access after purchase
  • No DRM
  • PDF download
OnDemand:
(Individual Chapters)
Available
$37.50
TOTAL SAVINGS: $37.50
Benefits
  • Purchase individual chapters from this book
  • Immediate PDF download after purchase or access through your personal library
Effective immediately, IGI Global has discontinued softcover book production. The softcover option is no longer available for direct purchase.
Description & Coverage
Description:

Parkinson’s disease is the second most common neurodegenerative disorder in the world after Alzheimer’s disease. Thanks to the pioneering works of Arvid Carlson in the 20th century identifying dopamine as the main neurochemical agent involved in Parkinson’s disease’s onset and progress, our understanding of the neuropathology has increased. The elaboration of L-Dopa as the first pharmacological treatment approach has brought new hope for curing or at least slowing the neurodegenerative progress and the decline of motor and cognitive functions in Parkinson’s disease patients. To date, imaging techniques along with genetic and biochemical tools have allowed scientists and clinicians to predict and diagnose the disease several years prior to the motor disorder’s appearance.

Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease sheds light on the history of Parkinson’s disease as well as the recent literature on the epidemiological data worldwide including the prevalence of the disease, the morbimortality rates, and the sex dimorphism and aging components. It addresses the current neuropathological evidence of Parkinson’s disease, including the latest discoveries in terms of neuropathology and treatments available or under clinical trials with the efficacy and limitations of each. Covering topics such as epidemiology, stem cells, and neuropathology, this premier reference source is an excellent resource for clinicians, physicians, epidemiologists, neuroscientists, microbiologists, biochemists, pharmacologists, toxicologists, medical professionals, nurses, medical students and educators, librarians, researchers, and academicians.

Coverage:

The many academic areas covered in this publication include, but are not limited to:

  • Diagnosis
  • Epidemiology
  • Hydrocarbons Exposure
  • Neuropathology
  • Non-Motor Features
  • Parkinson’s Disease
  • Pathogenesis
  • Pathophysiology
  • Stem Cells
  • Treatment
Table of Contents
Search this Book:
Reset
Editor/Author Biographies
|Ahmed Draoui - Editor|
|Omar El Hiba - Editor| is professor of physiopathology, neuroscience and histology, Faculty of Sciences, Chouaib Doukkali University, He was born in 12 September 1985 in Marrakech-Safi state (Morocco) and was graduated in 2007 from Cadi Ayyad University (Morocco) with a bachelor degree in Biology. In 2009, he was graduated from the same university with Master’s degree in Life and Health Sciences. He obtained his PhD in 2015 on the “Physiopathology of Hepatic Encephalopathy” from Cadi Ayyad University. He is, since 2014, member of the International Parkinson and Movement Disorders Society (MDS), USA and the vice-President of the Moroccan Society of Ethics and Animal Research (MoSEAR).
|Arumugam Jayakumar - Editor|
Archiving
All of IGI Global's content is archived via the CLOCKSS and LOCKSS initiative. Additionally, all IGI Global published content is available in IGI Global's InfoSci® platform.